Lavoisier S.A.S.
14 rue de Provigny
94236 Cachan cedex
FRANCE

Heures d'ouverture 08h30-12h30/13h30-17h30
Tél.: +33 (0)1 47 40 67 00
Fax: +33 (0)1 47 40 67 02


Url canonique : www.lavoisier.fr/livre/sciences-de-la-vie/biotechnology-in-india-ii-advances-in-biochemical-engineering-biotechnology-vol-85/descriptif_2288600
Url courte ou permalien : www.lavoisier.fr/livre/notice.asp?ouvrage=2288600

Biotechnology in India II, Softcover reprint of the original 1st ed. 2003 Advances in Biochemical Engineering/Biotechnology Series, Vol. 85

Langue : Anglais

Coordonnateurs : Ghose Tarun K., Ghosh Purnendu

Couverture de l’ouvrage Biotechnology in India II
The biotechnology business in India with an increase from USD 500 million in 1997 and reaching an estimated USD 1 billion next year health related prod ucts accounting for 60%, agro and veterinary products together 15%, and con tract R&D, reagents, devices and supplies adding up to the remaining 25% of which the diagnostics share was about 10% of the total surely presented an encouraging picture even five years ago. While volumes have increased, the pat tern has not. According to a report, prepared by McKinsey & Co, India's Phar maceutical industry including domestic and export sales and contract services totals nearly USD 5 billion. Furthermore, the company optimistically projects the growth to a factor of five fold only if both the industry and the government are able to put in place achievable solutions that must take care of the formida ble obstacles preventing further growth. If this assessment is correct, then the established transformation made by IT growth should also provide the confi dence required by the high expectations for biotechnology which have arisen in the country in recent years. Some contributors to this are overenthusiastic these are bureaucrats, some retired scientists and of course the complacent politicians who have the least knowledge of what the new biotechnology is all about. However, there are clear indications of biotechnology growth demon strated by a few but rapidly expanding biotech companies such as Biocon Ltd, Shantha Biotech (P) Ltd, Dr.
Bioethanol in India: Recent Past and Emerging Future.- Commercialization of a Novel Fermentation Concept.- Bioprocessing of Therapeutic Proteins from the Inclusion Bodies of Escherichia coli.- Research and Application of Microbial Enzymes — India’s Contribution.- Molecular Mechanisms of Energy Transduction in Cells: Engineering Applications and Biological Implications.- Status of Immunodiagnosis and Immunocontraceptive Vaccines in India.- Medical Biotechnology in India.

This review series covers trends in modern biotechnology

All aspects of this interdisciplinary technology, where knowledge, methods and expertise are required from chemistry, biochemistry, microbiology, genetics, chemical engineering and computer science, are treated

Electronic version available at http://link.springer.de/series/abe/

Date de parution :

Ouvrage de 304 p.

15.5x23.5 cm

Disponible chez l'éditeur (délai d'approvisionnement : 15 jours).

Prix indicatif 210,99 €

Ajouter au panier

Date de parution :

Ouvrage de 304 p.

15.5x23.5 cm

Sous réserve de disponibilité chez l'éditeur.

Prix indicatif 210,99 €

Ajouter au panier